Dave was previously a Senior Associate of Ferghana Partners with responsibility for analytical work and transaction support for a variety of therapeutics, diagnostics and research tools clients. Before joining Ferghana, Dave worked at America's Growth Capital as a Senior Biotechnology Analyst conducting equity research on emerging small cap biotechnology companies for institutional investors. Dave also worked as a Senior Biotechnology Analyst at Rodman & Renshaw where he covered small cap biotechnology companies, and as an Associate Analyst for Stephens Inc. where he conducted research on companies with drug discovery tools and enabling technologies.

Dave received a BA with honors in biology from Bowdoin College. He also received a PhD in Molecular Oncology and Immunology from New York University School of Medicine and conducted postdoctoral studies at Harvard Medical School/Children's Hospital Boston. Dave and his family live in the Back Bay. He enjoys running (when not battling injuries) and traveling and looks forward to the next occasion he and his wife can visit Italy.